Patient Monitoring Devices Market Summary
The Patient Monitoring Devices Market Size is anticipated to grow from USD 51,549.43 million in 2024 to USD 110,387.09 million by 2032, reflecting a CAGR of 10.01% during the forecast period (2025–2032). Patient monitoring devices are medical instruments used to continuously track, record, and display patients’ vital signs such as heart rate, blood pressure, oxygen levels, temperature, and respiratory rate, helping healthcare providers ensure timely diagnosis, treatment, and management of health conditions.
The market is being primarily driven by the rising prevalence of chronic disorders such as cardiovascular diseases and diabetes, increasing demand for remote patient monitoring, and accelerating technological advancements including AI integration, IoT connectivity, and wireless wearables.
Key companies operating in the patient monitoring devices market include Medtronic, GE Healthcare, Philips Healthcare, Abbott Laboratories, Siemens Healthineers, Nihon Kohden Corporation, Masimo Corporation, Omron Healthcare Co., Ltd., Smiths Medical, Hillrom, Welch Allyn, Inc., Natus Medical Incorporated, Mindray Medical International Limited, Nonin Medical, Inc., Spacelabs Healthcare, and others.
In July 2025, Cardiosense received FDA 510(k) clearance for its CardioTag device, a wearable sensor capable of simultaneously capturing electrocardiogram (ECG), photoplethysmogram (PPG), and seismocardiogram (SCG) signals, along with heart and pulse rate measurements.
Awareness around chronic disease monitoring is steadily increasing, driven by advancements in wearable technology, AI-powered diagnostics, and improved remote care infrastructure. As a result, the patient monitoring devices market is expected to witness significant growth in the coming years, supported by rising demand for real-time health tracking and broader healthcare access.
Explore DelveInsight’s Full Coverage on the Patient Monitoring Devices Market
Patient Monitoring Devices Overview
Patient monitoring devices are medical instruments used to continuously track, record, and display patients’ vital signs such as heart rate, blood pressure, oxygen levels, temperature, and respiratory rate. These devices help healthcare providers ensure timely diagnosis, treatment, and management of health conditions across a range of care settings – from intensive care units and hospitals to ambulatory surgical centers and home healthcare environments.
The rising prevalence of chronic disorders such as cardiovascular diseases and diabetes, coupled with the growing demand for remote patient monitoring, is driving the adoption of patient monitoring devices. Additionally, rapid technological advancements, including AI, IoT, and wearable innovations, along with continuous product development activities by key market players, are collectively boosting the overall market by enhancing device efficiency, accessibility, and patient care outcomes.
Patient Monitoring Devices Market Dynamics and Trends
The patient monitoring devices market is experiencing strong growth driven by the rising prevalence of chronic disorders such as cardiovascular diseases, diabetes, and respiratory conditions, which require continuous tracking of vital signs and disease progression.
The following are the key factors contributing to the growth of the patient monitoring devices market:
Rising prevalence of chronic disorders: The rising prevalence of chronic disorders such as cardiovascular diseases, diabetes, and respiratory conditions is significantly driving the demand for patient monitoring devices. These conditions require continuous tracking of vital signs and disease progression, leading to increased adoption of advanced monitoring solutions in hospitals, clinics, and home healthcare settings to ensure timely intervention and better patient outcomes. Approximately 590 million adults (20–79 years) were living with diabetes in 2024, with projections rising to 854 million by 2050.
Increasing demand for remote patient monitoring: The increasing demand for remote patient monitoring is escalating the market for patient monitoring devices, as healthcare providers and patients seek convenient, cost-effective, and real-time solutions for managing health outside hospital settings. The growing adoption of telehealth, wearable devices, and home-based monitoring systems is further boosting the integration of these technologies into routine care, driving overall market growth.
Increasing technological advancements in patient monitoring devices: Increasing technological advancements such as AI integration, IoT connectivity, wireless wearables, and advanced data analytics are boosting the market by enabling real-time, accurate, and user-friendly health monitoring. These innovations enhance patient outcomes, improve clinical decision-making, and drive wider adoption across hospitals, clinics, and home healthcare settings.
Patient Monitoring Devices Market Players
Key companies operating in the Patient Monitoring Devices market research landscape include:
- Medtronic
- GE Healthcare
- Philips Healthcare
- Abbott Laboratories
- Siemens Healthineers
- Nihon Kohden Corporation
- Masimo Corporation
- Omron Healthcare Co., Ltd.
- Smiths Medical
- Hillrom
- Welch Allyn, Inc.
- Natus Medical Incorporated
- Mindray Medical International Limited
- Nonin Medical, Inc.
- Spacelabs Healthcare
- And Others.
Patient Monitoring Devices Market Segmentation
The patient monitoring devices market report offers a comprehensive overview highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Type of Devices, Application, End-User, and Geography.
Key Findings:
- Approximately 590 million adults (20–79 years) were living with diabetes in 2024, with projections rising to 854 million by 2050
- Around 80.5 million people were affected by respiratory conditions in 2025, including asthma, COPD, sleep apnea, and respiratory infections
- About 805,000 people in the United States had a heart attack in 2024
- In the United States, approximately 38.6 million people had diabetes in 2024, projected to increase to 43.5 million by 2050
- North America is projected to dominate the global patient monitoring devices market in 2024, accounting for approximately 43% of the total share
- Blood Glucose Monitoring Systems (BGMS) is anticipated to dominate the type of devices segment, accounting for around 23% of the share in 2024
- Cardiology is anticipated to dominate the application segment, accounting for around 25% of the share in 2024
- The market is segmented across North America, Europe, Asia-Pacific, and Rest of the World
- The epidemiology and adoption of patient monitoring devices is expected to evolve significantly during the forecast period (2025–2032)
Download the Patient Monitoring Devices market report for in-depth insights on segmentation and forecast
Patient Monitoring Devices Market Outlook
The patient monitoring devices market trends point to continued expansion through the forecast period (2025–2032), driven by a rising patient population with chronic conditions, technological advancements, and a growing portfolio of innovative monitoring solutions.
The market is anchored by hospital-based monitoring systems and blood glucose monitoring solutions to manage chronic disease burden and enable timely clinical intervention. Advanced solutions like AI-integrated wearables and remote patient monitoring platforms are expanding access to care beyond traditional settings. Emerging technologies such as AI-powered diagnostic tools, 5G connectivity, Brain-Computer Interfaces, and ultra-wideband real-time location systems are expected to reshape the long-term monitoring landscape.
Key patient monitoring devices companies – including Medtronic, GE Healthcare, Philips Healthcare, Abbott Laboratories, and others – are investing in product development, strategic partnerships, and acquisitions to evaluate and strengthen their portfolios across various monitoring segments.
Patient Monitoring Devices Market Segment Analysis
By Type of Devices: Blood Glucose Monitoring Systems (BGMS) Category Dominates the Market
Within the type of devices segment, Blood Glucose Monitoring Systems (BGMS) are anticipated to dominate, accounting for around 23% of the share in 2024, due to the rising prevalence of diabetes worldwide. The need for continuous and accurate glucose monitoring has encouraged both patients and healthcare providers to adopt advanced BGMS, including continuous glucose monitors (CGMs) and smart glucometers integrated with mobile health applications.
The integration of BGMS with artificial intelligence and cloud-based platforms allows predictive analytics, helping clinicians optimize treatment plans. Government initiatives promoting diabetes awareness, reimbursement policies for home-based monitoring, and the rising adoption of remote patient monitoring solutions in both developed and emerging markets are also fueling demand. In September 2024, the FDA approved the Eversense 365, the first implantable continuous glucose monitoring system designed to function for an entire year, developed by Senseonics and Ascensia Diabetes Care.
By Application: Cardiology Category Dominates the Market
Within the application segment, cardiology is anticipated to dominate, accounting for around 25% of the share in 2024, due to the increasing burden of cardiovascular diseases globally and the growing need for continuous, real-time monitoring of heart health. Advances in wearable and implantable cardiac devices – such as continuous ECG monitors, implantable loop recorders, and AI-powered arrhythmia detection systems – allow clinicians to detect and manage conditions like atrial fibrillation, heart failure, and other cardiac abnormalities more effectively.
In July 2025, Cardiosense received FDA 510(k) clearance for its CardioTag device, a wearable sensor capable of simultaneously capturing ECG, PPG, and SCG signals for comprehensive cardiac monitoring. The integration of AI and cloud-based analytics further facilitates predictive insights, personalized care, and seamless communication between patients and healthcare providers.
By End-User: Hospitals Dominate the Market
In the patient monitoring devices market, hospitals are expected to remain the largest end-user segment in 2024 due to their high patient volumes, critical care requirements, and the need for continuous monitoring of vital signs. Hospitals rely on advanced monitoring systems across intensive care units, cardiac care units, and emergency departments to ensure timely interventions, improve patient outcomes, and support complex clinical workflows. Their capacity to invest in sophisticated technologies and integrate devices with electronic health records further reinforces their dominant position in the market.
Patient Monitoring Devices Market Regional Analysis
North America Patient Monitoring Devices Market Trends
North America is projected to dominate the global patient monitoring devices market in 2024, accounting for approximately 43% of the total share, due to the high prevalence of chronic diseases, strong adoption of advanced healthcare technologies, and the widespread use of remote patient monitoring solutions supported by a well-established telehealth infrastructure. Favorable reimbursement policies, rising healthcare expenditure, and the presence of leading market players further strengthen the region’s leadership.
In 2024, approximately 38.6 million people in the United States had diabetes, projected to increase to 43.5 million by 2050. Additionally, about 805,000 people in the United States had a heart attack in 2024, driving demand for glucose monitors, wearable cardiac monitors, and remote monitoring systems.
Europe Patient Monitoring Devices Market Trends
Europe is driving growth in the patient monitoring devices market through its advanced healthcare infrastructure, high adoption of digital health technologies, and supportive regulations. Initiatives promoting remote monitoring, telemedicine, and home-based care are boosting the use of wearable and AI-powered devices for managing chronic conditions like cardiovascular diseases and diabetes. In July 2025, Boston Scientific received CE Mark approval for its LATITUDE® Patient Management System, enabling remote monitoring of patients with implantable cardiac devices and facilitating timely clinical interventions.
Asia-Pacific Patient Monitoring Devices Market Trends
Asia-Pacific is emerging as a major growth driver for the patient monitoring devices market due to the region’s large patient population, rising prevalence of chronic diseases, and increasing healthcare spending. Rapid adoption of digital health technologies, government initiatives supporting telemedicine and remote monitoring, and growing awareness of preventive care are driving demand for wearable devices, continuous glucose monitors, and multi-parameter monitoring systems.
Marketed Patient Monitoring Devices
- Viatom O2Ring – Apnimed
The Viatom O2Ring is a ring-shaped pulse oximeter that continuously tracks blood oxygen saturation (SpO₂) and heart rate, with built-in vibration alerts for threshold breaches. It enhances remote patient monitoring capabilities and improves patient compliance. In February 2025, the FDA approved the Viatom O2Ring for continuous oxygen and heart rate monitoring.
- Eversense 365 – Senseonics and Ascensia Diabetes Care
The Eversense 365 is the first implantable continuous glucose monitoring system designed to function for an entire year. This device represents a significant advancement in long-term glucose monitoring technology, offering extended wear time and eliminating the need for frequent sensor replacements. In September 2024, the FDA approved the Eversense 365 for long-term continuous glucose monitoring.
Download the Patient Monitoring Devices market report for in-depth insights on marketed products and competitive landscape
Emerging Patient Monitoring Devices
The patient monitoring devices market size is expected to evolve significantly, supported by an active pipeline of emerging technologies addressing substantial unmet need. Key emerging innovations include the CardioTag, AI-powered wearable systems, multi-parameter monitoring devices, and remote patient monitoring platforms, among others, with active development programs targeting novel mechanisms, improved tolerability, and comprehensive disease monitoring.
- CardioTag – Cardiosense
The CardioTag is a wearable sensor capable of simultaneously capturing electrocardiogram (ECG), photoplethysmogram (PPG), and seismocardiogram (SCG) signals, along with heart and pulse rate measurements. This multimodal approach allows for comprehensive cardiac monitoring, aiding in the assessment of heart function and the detection of potential issues. In July 2025, Cardiosense received FDA 510(k) clearance for the CardioTag device.
- Kendall DL™ Multi System – Cardinal Health
The Kendall DL™ Multi System is a single-patient use monitoring cable that continuously tracks cardiac activity, blood oxygen levels, and temperature, streamlining patient monitoring from admission to discharge. In June 2025, Cardinal Health launched the Kendall DL™ Multi System.
- Dexcom G7 15-Day CGM – Dexcom
The Dexcom G7 15-Day continuous glucose monitoring (CGM) system offers an extended wear time of up to 15.5 days, enhancing convenience for diabetes patients. In April 2025, Dexcom secured FDA clearance for its G7 15-Day CGM system.
Patient Monitoring Devices Competitive Landscape
The patient monitoring devices market is defined by a competitive landscape that is partially consolidated at the top, with a strong presence of a few major players, but fragmented in the specialized and emerging technology segments. Traditional medical device giants like Medtronic, GE HealthCare, and Philips Healthcare hold a dominant market share, particularly in high-acuity, hospital-based monitoring systems and established categories like cardiac and multiparameter monitoring.
The market is becoming increasingly competitive due to the rise of specialized firms and consumer tech companies. Players like Abbott and Dexcom are dominating the continuous glucose monitoring (CGM) sub-segment, while innovative startups are carving out niches in remote patient monitoring and neuro-monitoring. Key strategic responses include a strong focus on technological innovation, AI integration for predictive analytics, and a push for greater portability and wireless connectivity to serve the fast-growing home care and ambulatory settings. Mergers and acquisitions remain a key strategy, with large firms acquiring smaller, innovative companies to gain access to new technologies and expand market presence.
Explore DelveInsight’s Full Coverage on the Patient Monitoring Devices Market
Conclusion
The Patient Monitoring Devices market is poised for meaningful growth through 2032, supported by an increasing chronic disease burden, heightened awareness, and continued advancements in monitoring technology. While hospital-based systems and blood glucose monitors remain the cornerstone of patient monitoring, persistent unmet needs – particularly in remote care access, continuous monitoring for respiratory and neurological conditions, and reduction of data overload and alarm fatigue – are driving the development of next-generation monitoring solutions with novel capabilities.
Promising innovations such as the CardioTag (Cardiosense), Dexcom G7 15-Day CGM, and Eversense 365 have the potential to reshape the monitoring landscape and enhance patient outcomes. As research progresses and access to innovative devices expands, the Patient Monitoring Devices market is expected to witness significant transformation, creating new opportunities for stakeholders while addressing the long-term challenges associated with chronic and critical disease management.
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharmaceutical companies by providing comprehensive end-to-end solutions to improve their performance. It also offers healthcare consulting services that leverage market analysis to accelerate business growth and overcome challenges with practical approaches.
Media contact
Name: Abhishek kumar
E-mail: abhishek@delveinsight.com
